Position in ARCT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$108,474
New position
Shares Held
16,142
first reported quarter
Ownership
0.057%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $15,596,410 across 69 Biotechnology names. ARCT ranks #36 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,394 | $1,010,188 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,389 | $745,823 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
13,570 | $745,535 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,329 | $678,896 | |
| 5 | TWST |
Twist Bioscience Corp
|
5,323 | $547,630 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
4,681 | $536,770 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
4,286 | $525,377 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,050 | $521,566 |
All Filings in ARCT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,474 | 16,142 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||